Thanks to a strong rebound in Q2, the combined market cap of biopharma companies increased by $190 billion compared with the end of 2019, according to the Pharma, Biotech and Medtech Half-Year Review 2020. Here are the world’s most valuable drug and biotech companies, as of August 14, 2020.
